VWF and Cirrhosis: In particular, the dynamic changes in vWF and ADAMTS13 levels across advancing stages of cirrhosis could serve as early indicators of ACLF risk, offering a potential tool for identifying patients who may benefit from closer monitoring [6,10,40,41].